Form 10-Q REXAHN PHARMACEUTICALS, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Rexahn Pharma (RNN) Posts Narrower than Expected Q3 Loss of 1c/Share
November 13, 2014 7:44 AM ESTRexahn Pharma (AMEX: RNN) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02).
The company ended the quarter with about $35.59 million in cash.
September 30, 2014 December 31, 2013 ASSETS Current Assets: Cash and cash equivalents $14,971,660 $18,688,031 Marketable securities (note 3) 20,613,885 100,000For earnings history and earnings-related data on Rexahn Pharma (RNN) click here.
... More